Guangzhou Aige Biotechnology Co., Ltd.

The Aige Group was founded in 2008, and is a pharmaceutical enterprise group integrating research, production, and sales, with over 500 employees, annual sales of 500 million yuan, and profits and taxes of over 80 million yuan.\nGuangzhou Aige is a high-tech enterprise in Guangdong Province, a Science and Technology Innovation Small Giant Enterprise in Guangzhou, a Gazelle Enterprise in Guangzhou, a Guangzhou Enterprise Research and Development Institution, and a member of the Guangzhou Industry-University-Research Collaborative Innovation Alliance. The company is located in Guangzhou Huangpu Science City, with a laboratory area of approximately 4,500 square meters, over 150 full-time scientific researchers, and more than 70 large-scale precision instruments including high-performance liquid chromatographs and gas chromatographs. It has established the Waters Empower3 chromatography data network management system and a local intranet security system.\nGuangzhou Aige is the Guangdong Provincial Engineering Technology Research Center for New Drug Development, focusing on drug technology development and committed to the development of high-end generic drugs and innovative drugs. It is a leading preclinical drug R&D service platform in South China, providing a series of preclinical drug development services to large and medium-sized domestic enterprises such as Guangyao Group, Yangtze River Pharmaceutical Group, Kunming Pharmaceutical Group, Qianjin Pharmaceutical, Guizhou Bailing, and Harbin Pharmaceutical Group's Sanlian. It achieves full-chain coverage from R&D to clinical trials, production, and sales in the pharmaceutical field, becoming the first enterprise in South China to provide professional one-stop "CRO+" services.